D J Kereiakes
Overview
Explore the profile of D J Kereiakes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
1536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurm H, Bhatt D, Lincoff A, Tcheng J, Kereiakes D, Kleiman N, et al.
Heart
. 2003 Sep;
89(10):1200-4.
PMID: 12975419
Background: Raised inflammatory markers are associated with worse outcome after percutaneous coronary interventions (PCI). An increase in the white blood cell (WBC) count is a non-specific response to inflammation. We...
2.
Casterella P, Kereiakes D, Steinhubl S, Raymond R, Kottke-Marchant K, Patel K, et al.
Catheter Cardiovasc Interv
. 2001 Dec;
54(4):497-504.
PMID: 11747189
The platelet function dose-response to incremental abciximab (Reopro, Eli Lilly/Centocor, Indianapolis, IN) bolus dosing during percutaneous coronary intervention (PCI) was evaluated in 85 patients using a point-of-service platelet function assay....
3.
Kereiakes D, Lorenz T, Young J, Kukielka G, MUELLER M, Phillips D
J Thromb Thrombolysis
. 2001 Dec;
12(2):123-7.
PMID: 11729363
Background: High levels of glycoprotein (GP) IIb/IIIa receptor inhibition are required to prevent arterial thrombosis following percutaneous coronary intervention. Ex-vivo turbidometric platelet aggregation in citrate anticoagulated blood samples has been...
4.
Henry T, Rocha-Singh K, Isner J, Kereiakes D, Giordano F, Simons M, et al.
Am Heart J
. 2001 Oct;
142(5):872-80.
PMID: 11685177
Background: Patients with severe myocardial ischemia who are not candidates for percutaneous or surgical revascularization have few therapeutic options. Therapeutic angiogenesis in animal models with use of recombinant human vascular...
5.
Furman M, Kereiakes D, Krueger L, MUELLER M, Pieper K, Broderick T, et al.
Am Heart J
. 2001 Oct;
142(5):790-8.
PMID: 11685164
Background: Plaque disruption with resultant platelet activation and leukocyte-platelet aggregation is a pathophysiologic process common to both acute coronary syndromes and percutaneous coronary interventions. Unfractionated heparin is a standard antithrombotic...
6.
Low molecular weight heparin therapy for percutaneous coronary intervention: a practice in evolution
Choo J, Kereiakes D
J Thromb Thrombolysis
. 2001 Sep;
11(3):235-46.
PMID: 11577263
Unfractionated heparin (UFH) remains the principal antithrombotic agent during percutaneous coronary intervention (PCI) but is associated with significant limitations including an unpredictable anticoagulation dose response, the requirement for frequent monitoring,...
7.
Tcheng J, Kereiakes D, Lincoff A, GEORGE B, Kleiman N, Sane D, et al.
Circulation
. 2001 Aug;
104(8):870-5.
PMID: 11514371
Background: Platelet glycoprotein IIb/IIIa blockade with abciximab (ReoPro) improves the clinical outcomes of percutaneous coronary intervention. This registry was conducted to characterize the effects of repeated administration of abciximab during...
8.
Roe M, Cura F, Joski P, Garcia E, Guetta V, Kereiakes D, et al.
Am J Cardiol
. 2001 Jul;
88(2):170-3, A6.
PMID: 11448417
The feasibility and safety of simultaneous multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction was analyzed in a retrospective, case-controlled study. Patients who underwent multivessel coronary intervention...
9.
Lincoff A, Kereiakes D, Mascelli M, Deckelbaum L, Barnathan E, Patel K, et al.
Circulation
. 2001 Jul;
104(2):163-7.
PMID: 11447080
Background: Previous investigators have shown that systemic markers of inflammation may be increased in patients with acute ischemic syndromes or after percutaneous coronary revascularization and that persistent elevation in these...
10.
Kandzari D, BEHAR V, Sketch Jr M, Kereiakes D, Shimshak T, Broderick T, et al.
J Invasive Cardiol
. 2001 Jul;
13(7):538-42.
PMID: 11435643
No abstract available.